ISPOR, the professional society for health economics and outcomes research-;explored the issue of drug pricing in the session, “Time for Change? Has the Time Come for the Pharma Industry to Accept Modest Prices?” [IP4].
From https://jamesjohnson10.blogspot.com/2019/11/panelists-explore-issue-of-drug-pricing.html
from
https://jamesjohnson10.wordpress.com/2019/11/05/panelists-explore-the-issue-of-drug-pricing-at-ispor-europe-2019/
No comments:
Post a Comment